MedPath

Investigation of the therapeutic effect of Dapagliflozin in infertile women with polycystic ovary syndrome (PCOS) undergoing IVF

Phase 2
Recruiting
Conditions
Polycystic ovary syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20240303061157N1
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
80
Inclusion Criteria

Infertile women with classic polycystic ovary syndrome
Infertile women between 20 and 42 years old

Exclusion Criteria

Hypersensitivity to metformin or SGLT-2 inhibitors
Pregnancy
Diabetes
Male infertility

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
o. of Oocyte retrieved. Timepoint: once, in day of puncture. Method of measurement: Oocyte retrieval was performed by ultrasound-guided transvaginal aspiration using a single-lumen needle.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath